AstraZeneca | Investor Conference Presentation Deck

Slide schematic 6/6

callout 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 2/2

Components 6

primary bullet paragraph source-note action-title headline

Tools 1

list/bullet: Small molecules, Antibody therapeutics, Nucleotide-based therapeutics, Cell-based therapeutics, Peptide/protein therapeutics, in vivo-expressed biologics

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

Growth Through Innovation 80%

Explicitly stated as the strategic framework for R&D investment.

Find anything

The slide uses a 'Growth Through Innovation' framework to categorize R&D focus areas.